Agenda

Return

C. 50

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	May 9, 2023

Contra

Costa

County

Subject:

Contract #23-751 with Bluesight, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 05/09/2023

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Ken Carlson, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:

Rajiv Pramanik 925-765-8689

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: May 9, 2023
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County Contract #23-751 with Bluesight, Inc., a corporation, in an amount not to exceed $22,940, for controlled substances inventory management software at Contra Costa Regional Medical Center (CCRMC), for the period from May 9, 2023, through May 8, 2024.

FISCAL IMPACT:

Approval of this contract will result in annual expenditures of up to $22,940 and will be funded as budgeted by the department in FY 2023-24, by 100% Hospital Enterprise Fund I revenues.

BACKGROUND:

This contract meets the needs of the County’s population by providing a SaaS solution regarding controlled substances. Bluesight for Controlled Substances Module is an artificial intelligence for medication management and drug diversion solution. It uncovers the mismanagement of controlled substances utilizing a substance surveillance mechanism that is an operational necessity and legal and regulatory requirement. It provides the County with an enhanced monitoring tool enabling better service to the patient population while supporting compliance with the language of the law.

While CCRMC has had an ongoing business relationship with Bluesight company for years for their RFID product, the Bluesight for Controlled Substances Module is a new service. Currently, (Pandora) is the vendor providing these services to CCRMC, but no longer supported by Omnicell. Thus, CCRMC must discontinue using that solution. CCRMC pharmacy staff reviewed offerings from other vendors such as Protenus, Medacist (RxAuditor), KLAS Research reports for the Drug Diversion Monitoring program, and Invistics. However, Staff chose the Bluesight solution for its ability to provide pertinent information regarding drug diversion and monitoring. Bluesight (Previously KitCheck) is now at the forefront of this software niche.

The contract obligates County to indemnify Bluesight against third party claims arising out of County’s breach of the contract or its negligence or willful misconduct in performing the contract.

Approval of this new contract #23-751 allows the contractor to provide software as a service through May 8, 2024.

CONSEQUENCE OF NEGATIVE ACTION:

If this contract is not approved, CCRMC will lose its ability to proactively monitor controlled substances resulting in the mismanagement of medication that includes operational, legal, and regulatory issues.